The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year for the Wegovy pill and up to $1,200 a year for the Wegovy injection with a 12-month subscription, pharmaceutical giant Novo Nordisk announced on Tuesday, March 31. NBC's Anne Thompson reports on the details.
2:38
The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year for the Wegovy pill and up to $1,200 a year for the Wegovy injection with a 12-month subscription, pharmaceutical giant Novo Nordisk announced on Tuesday, March 31. NBC's Anne Thompson reports on the details.
284.9K views5 months ago
TikToktodayshow
See more
Static thumbnail place holder